Announcing Axiom: Eliminating drug toxicity, without using animals! Alex Beatson and I founded Axiom a little over over a year ago with the mission of eliminating drug toxicity by replacing traditional experiments, such as animal testing, with AI models. We are excited to

blog.newlimit.com/p/newlimit-rai…

we're entering a new phase NewLimit & beginning to progress our first medicines for aging & disease. now more than ever, we're confident that reprogramming biology will unlock more healthy years in each life. it's a privilege to build this future with generational partners.

We’ve raised a $130 million Series B led by Kleiner Perkins alongside new investors Nat Friedman/Daniel Gross , Vinod Khosla, and HUMAN CAPITAL — joined by existing investors Founders Fund , DIMENSION, and Brian Armstrong (yes, the cofounders are doubling down). We also raised

Leading NewLimit's Series A was amongst the first investments we made at DIMENSION. Today is pivotal, bringing in new proceeds & iconic world class investors, as we continue the march to slow & reverse aging. Congrats to Jacob Kimmel Blake Byers & Brian Armstrong!

Incredible alignment of team, mission, technology, and science tackling one of the largest developing areas of life science. Congrats on the raise!! Jacob Kimmel Blake Byers Brian Armstrong Grateful to be along for the journey DIMENSION

Jacob Kimmel is an extraordinarily talented speaker and brilliant scientist. Whether he knows it or not, I began following Jacob's work years ago as I was kicking off my own journey into epigenetics. Despite being aware of epigenetic control since high school, my previous

To replace animal testing with AI, we need MASSIVE human datasets. Today, we're thrilled to share Axiom's new data exploration tool, providing the ability to visually explore the world's largest primary human liver toxicity dataset. Built with Axiom's proprietary wetlab

#ASCO25 was full of practice-changing data and provocative science projects. In this essay, we've distilled four key topics that've stuck with us since. Read on.

Incredible work from the Chai team!

We are hiring! I don't tend to talk about the success of Tamarind Bio publicly, but we are experiencing incredible demand. Tens of thousands of scientists are regularly using the platform, and we're onboarding GPUs and people as fast as we can. We just posted multiple roles

Congrats to Joshua, Jack, and the stellar team at Chai Discovery!! They are doing incredible work to advance generative protein design and make biology programmable for the first time. This is just the beginning, DIMENSION is excited to continue to partner with Chai on

Excited to introduce our newest team member, Sriram (“Rami”) Hathwar! 🚀 From winning the US Scripps National Spelling Bee, to enrolling in a Chemistry/Bio/CS curriculum at Princeton, to developing bioinformatics tools at a clinical stage biotech, Rami embodies the

We've raised $8.6m to build leading AI tools for the biopharma industry! Our seed financing was led by Kleiner Perkins and DIMENSION , with participation from ACME Capital, Comma Capital, Liquid 2 Ventures, Not Boring, Audacious Ventures, Lux Capital, and leaders in AI and biotechnology

I'm extremely excited to be partnering with Alex Telford (Alex Telford), Maged Korga Ahmed, Vikas Velagapudi, Merouane Ounadjela, and team as they build Convoke! AI/ML tooling will undoubtedly supercharge biotech's ability to develop drug candidates more quickly and inexpensively than

A thread about the unreasonable effectiveness of writing on the internet, or how I got 8.6 million dollars from a blog post